Distinct prognostic values and potential drug targets of ALDH1 isoenzymes in non-small-cell lung cancer
Qinghua You,1 Huanchen Guo,2 Dongxiang Xu3 1Department of Pathology, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, 2Department of Respiratory Medicine, Shouguang Hospital of Traditional Chinese Medicine, Shouguang, 3Department of Endocrinology, Shanghai Pudong Hospital,...
Saved in:
Main Authors: | You Q (Author), Guo H (Author), Xu D (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2015-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of ALDH2 in tumorigenesis and tumor progression: Targeting ALDH2 as a potential cancer treatment
by: Hong Zhang, et al.
Published: (2021) -
Evaluation of Predictive Values of Naples Prognostic Score in Patients with Unresectable Stage III Non-Small Cell Lung Cancer
by: Guo D, et al.
Published: (2021) -
A meta-analysis for CXCR4 as a prognostic marker and potential drug target in non-small cell lung cancer
by: Zhang C, et al.
Published: (2015) -
Comprehensive analysis of prognostic value and immune infiltration of kindlin family members in non-small cell lung cancer
by: Xiaoshan Su, et al.
Published: (2021) -
Prognostic value of lung immune prognostic index in non-small cell lung cancer patients receiving immune checkpoint inhibitors: a meta-analysis
by: Yi Wang, et al.
Published: (2024)